| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 20, 2002
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Aug 2, 2002
The Perrigo Company (NASDAQ: PRGO) today announced financial results for the full year and fourth quarter ended June 29, 2002. Fiscal Year 2002 For fiscal 2002, Perrigo's sales increased 10...
-
Jul 30, 2002
Perrigo Company (NASDAQ: PRGO) announces the following Webcast: What: Perrigo's 2002 Fourth Quarter and Year-End Earnings Release When: Friday, August 2, 2002 at 11 a.m. Eastern Where:...
-
Jul 17, 2002
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Apr 25, 2002
Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months ended March 30, 2002. Net sales for the third quarter were $198.5 million, an increase of four percent...
-
Apr 23, 2002
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its third quarter fiscal 2002 on Thursday, April 25, 2002 at approximately 8:30 a.m. EDT. The Company will...
-
Apr 5, 2002
The Perrigo Company (NASDAQ: PRGO) invites the public to access a webcast of the Company's presentation at the Banc of America Securities Consumer Conference on Monday, April 8 at 3:30 p.m. (EDT)....
-
Apr 4, 2002
The Perrigo Company (NASDAQ: PRGO), the nation's leading manufacturer of store brand over-the-counter pharmaceuticals, vitamins and nutritional supplements, announced today that it is the first...
-
Jan 23, 2002
Perrigo Company (NASDAQ: PRGO) today announced results for the second quarter and six months ended December 29, 2001. Net sales for fiscal 2002's second quarter increased 21 percent to $228.7...
-
Jan 21, 2002
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its second quarter fiscal 2002 ended December 29, 2001, on Wednesday, January 23, 2002 at approximately...
-
Dec 4, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market over-the-counter (OTC) tioconazole...
-
Oct 23, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal 2002 ended September 29, 2001. Net sales for fiscal 2002's first quarter increased 13 percent to $217.1...
-
Oct 19, 2001
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fiscal 2002 first quarter ended September 29, 2001, on Tuesday, October 23, 2001 at approximately 8:30...
-
Oct 11, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share...
-
Aug 15, 2001
Perrigo Company today announced that, in cooperation with the U.S. Food and Drug Administration (FDA), it is conducting a recall of 7,788 four-ounce bottles of cherry-flavored pain reliever...
-
Aug 15, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the fourth quarter and fiscal year ended June 30, 2001. For the fourth quarter, net sales were $180.9 million, an increase of 19 percent...
-
Aug 2, 2001
Perrigo Company (NASDAQ: PRGO) today announced preliminary results for the Company's fiscal 2001 fourth quarter, which ended June 30, 2001. For the fourth quarter, Perrigo expects to report net...
-
Jun 29, 2001
The Perrigo Company (NASDAQ: PRGO) today announced it has acquired Wrafton Laboratories Ltd., a store brand supplier to grocery and pharmacy retailers in the U.K. and a contract manufacturer of...
-
Jun 7, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it has received approval to market and distribute Ibuprofen and Pseudoephedrine Hydrochloride Tablets USP, 200 mg and 30 mg respectively,...
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it will shortly begin shipping Famotidine 10 mg tablets through an agreement with Teva Pharmaceutical Industries Ltd. The terms of the...
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced an agreement to purchase Wrafton Laboratories Ltd., a subsidiary of McBride plc (LONDON: MCB) for $44 million. Wrafton Laboratories is a supplier...
-
May 18, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its presentation scheduled for Wednesday, May 23, 2001 at 8 a.m. EDT at the UBS Warburg Global Specialty Pharmaceuticals Conference in New...
-
May 1, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months ended March 31, 2001. Net sales for the quarter were $192.0 million, an increase of four percent...
-
Apr 25, 2001
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fiscal 2001 third quarter ended March 31, 2001, on Tuesday, May 1, 2001 at approximately 8:30 a.m....
-
Feb 15, 2001
The Perrigo Company (NASDAQ: PRGO) today announced a new addition to the Company's management team: Matthew E. Morris as Senior Vice President and Chief Information Officer. Mr. Morris brings to...